A detailed history of M&G Investment Management LTD transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, M&G Investment Management LTD holds 8,826 shares of EW stock, worth $598,049. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,826
Previous 8,826 -0.0%
Holding current value
$598,049
Previous $671 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024

BUY
$61.71 - $77.76 $53,255 - $67,106
863 Added 10.84%
8,826 $671 Million
Q3 2023

Nov 13, 2023

BUY
$69.28 - $93.38 $1,316 - $1,774
19 Added 0.24%
7,963 $549 Million
Q2 2023

Aug 01, 2023

SELL
$81.41 - $94.33 $97,447 - $112,913
-1,197 Reduced 13.09%
7,944 $747 Million
Q1 2023

May 11, 2023

SELL
$74.26 - $84.51 $2.75 Million - $3.13 Million
-37,025 Reduced 80.2%
9,141 $756,000
Q4 2022

Jan 27, 2023

BUY
$68.3 - $87.44 $3.15 Million - $4.04 Million
46,166 New
46,166 $0
Q1 2022

May 13, 2022

SELL
$101.96 - $128.34 $177,002 - $222,798
-1,736 Closed
0 $0
Q4 2021

Jan 18, 2022

SELL
$106.37 - $130.68 $46.2 Million - $56.8 Million
-434,355 Reduced 99.6%
1,736 $226,000
Q3 2021

Nov 09, 2021

BUY
$102.91 - $122.75 $10.6 Million - $12.6 Million
102,943 Added 30.9%
436,091 $49.4 Million
Q2 2021

Aug 16, 2021

BUY
$83.84 - $104.76 $27.7 Million - $34.6 Million
330,538 Added 12664.29%
333,148 $34.6 Million
Q1 2021

May 12, 2021

SELL
$78.68 - $90.67 $17,939 - $20,672
-228 Reduced 8.03%
2,610 $219,000
Q3 2020

Oct 26, 2020

BUY
$67.19 - $87.44 $190,685 - $248,154
2,838 New
2,838 $227,000
Q2 2020

Jul 22, 2020

SELL
$57.54 - $76.95 $336,954 - $450,619
-5,856 Closed
0 $0
Q4 2019

Jan 28, 2020

BUY
$71.7 - $82.09 $419,875 - $480,719
5,856 New
5,856 $1.36 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track M&G Investment Management LTD Portfolio

Follow M&G Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&G Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on M&G Investment Management LTD with notifications on news.